These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 4149575

  • 1. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A, Kostka-Trabka E, Gryglewski R.
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract] [Full Text] [Related]

  • 2. Central actions of some beta-adrenoceptor blocking agents.
    Shah UH, Jindal MN, Patel VK, Kelkar VV.
    Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D, Kawada T, Takeda K, Imai S.
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
    Dubach UC.
    Schweiz Rundsch Med Prax; 1975 Sep 30; 64(39):1239-41. PubMed ID: 241073
    [No Abstract] [Full Text] [Related]

  • 6. Cardiac toxicity of -lytic drugs.
    Roba J.
    Arch Int Pharmacodyn Ther; 1972 Apr 30; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological characterisation of -receptor blocking agents.
    Saameli K.
    Jpn J Pharmacol; 1972 Apr 30; 22():Suppl22:13. PubMed ID: 4403917
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH.
    Br J Pharmacol; 1973 Mar 30; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract] [Full Text] [Related]

  • 15. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W, Dietmann K, Leinert H, Sponer G.
    Arzneimittelforschung; 1977 Mar 30; 27(5):1022-6. PubMed ID: 18157
    [Abstract] [Full Text] [Related]

  • 16. Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats.
    Bartsch W, Sponer G, Dietmann K, Kohler M.
    Arzneimittelforschung; 1981 Mar 30; 31(11):1885-8. PubMed ID: 6119093
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
    Caputi AP, Marmo E, Saini RK.
    Res Commun Chem Pathol Pharmacol; 1972 Jul 30; 4(1):25-35. PubMed ID: 4152996
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
    Salimi M.
    Pharmacology; 1975 Jul 30; 13(5):441-7. PubMed ID: 1802
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.